30.07.2014 • News

BASF Breaks Ground on €90 Million Chinese R&D Expansion

BASF has broken ground on the €90 million expansion of its Innovation Campus Asia Pacific at Pudong, Shanghai, China.

The second phase of the project adds a regional research and development (R&D) building and auxiliary facilities to be completed by the end of 2015.

"By 2020, around 25% of BASF's R&D employees will be located in Asia Pacific. The expansion reinforces BASF's commitment to globalizing its R&D activities and capturing growth opportunities in China and Asia Pacific," said managing board member Andreas Kreimeyer, who has responsibility for R&D.

The Shanghai innovation campus, focuses primarily on advanced materials and systems but it also adds new areas such as formulations and chemical process and engineering for growth industries such as automotive, construction, health and nutrition, and home and personal care,. It is expected to become one of the German group's largest R&D sites outside its home country.

Some 18 months after its inauguration, BASF said the Innovation Campus Asia Pacific has strengthened its position as the preferred innovation partner for customers in the region, for example from the construction, automotive, paint and coatings, home and personal care and packaging industries.

What the group calls "the world's first co-extrudable PBT (Ultradur) for reinforcement of thermally insulated polyvinyl chloride (PVC) window profile" was developed at Shanghai together with Dalian Shide Group.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read